Patients with depressive symptoms and asthma had elevated levels of serum brain-derived neurotrophic factor in association ...

Pulmonary function tests are a group of noninvasive breathing tests that measure how much air your lungs can hold, how quickly you can move air in and out and how efficiently your lungs transfer ...

Children exposed to gestational diabetes had greater odds of having current wheeze (OR, 2.23) and current asthma (OR, 3.12) by 9 years of age. Gestational diabetes mellitus (GDM) exposure is ...

Dive into expert tips for the Marine PFT plank and three-mile run, including training strategies, pacing advice, and preparation plans to ensure maximum points and success for anyone aiming to become ...

1. Seahawks (last week No. 1; 14-3): If they can avoid the Rams, they’ll get back to the Super Bowl. 2. Patriots (No. 2; 14-3): The “easy schedule” talk ends now. 3. Jaguars (No. 3; 13-4): Can they ...

The U.S. Food and Drug Administration has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in adult and pediatric patients aged ...

The FDA approved depemokimab (Exdensur) as the first ultra-long-acting biologic with twice-yearly dosing approved for patients with severe asthma with an eosinophilic phenotype, GSK announced. The ...

A new option for hard-to-control asthma: The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma. Designed to reduce flare-ups: The injectable ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved depemokimab (Exdensur, GSK plc) as add-on therapy for severe asthma and for chronic rhinosinusitis with nasal polyps (CRSwNP ...

People with severe asthma sometimes rely on daily steroid pills, which raise the risk of diabetes, infections and bone problems. Now, a study supports the idea that a monthly antibody injection is a ...

Respiratory Pathophysiology Unit, Department of Cardiac-Thoracic-Vascular Sciences and Public Health, University of Padova, Padova, Italy Background: Severe asthma remains a major problem despite ...